1.This Act may be cited as the
Acquired Bone Marrow Failure Disease
Research and Treatment Act of 2010
.
2.Acquired Bone
Marrow Failure Disease ResearchPart B of title III of the Public Health
Service Act (42
U.S.C. 243 et seq.) is amended by inserting after section 317T
the following:
317U.Acquired Bone
Marrow Failure Disease Research
(a)The Secretary may
conduct research on acquired bone marrow failure diseases. Such research may
address factors including—
(1)trends in the characteristics of
individuals who are diagnosed with acquired bone marrow failure diseases,
including age, race and ethnicity, general geographic location, sex, family
history, and any other characteristics determined appropriate by the
Secretary;
(2)the genetic and
environmental factors, including exposure to toxins, that may be associated
with developing acquired bone marrow failure diseases;
(3)approaches to
treating acquired bone marrow failure diseases;
(4)outcomes for
individuals treated for acquired bone marrow failure diseases, including
outcomes for recipients of stem cell therapeutic products; and
(5)any other factors
pertaining to acquired bone marrow failure diseases determined appropriate by
the Secretary.
(b)Collaboration
with the Radiation Injury Treatment NetworkIn carrying out subsection (a), the
Secretary may collaborate with the Radiation Injury Treatment Network of the
C.W. Bill Young Cell Transplantation Program established pursuant to section
379 to—
(1)augment data for
the studies under such subsection;
(2)access technical
assistance that may be provided by the Radiation Injury Treatment Network;
or
(3)perform joint
research projects.
(c)In
this section, the term acquired bone marrow failure disease
means—
(1)myelodysplastic
syndromes (MDS);
(2)aplastic
anemia;
(3)paroxysmal
nocturnal hemoglobinuria (PNH);
(4)pure red cell
aplasia;
(5)acute myeloid leukemia that has progressed
from myelodysplastic syndromes;
(6)large granular
lymphocytic leukemia; or
(7)any other bone marrow failure disease
specified by the Secretary, to the extent such disease is acquired and not
inherited, as determined by the
Secretary.
.
3.Minority-focused
programs on acquired bone marrow failure diseasesTitle XVII of the Public Health Service Act
(42 U.S.C. 300u et
seq.) is amended by inserting after section 1707A the
following:
1707B.Minority-focused
programs on acquired bone marrow failure diseases
(a)Information and
referral services
(1)The Secretary may
establish and coordinate outreach and informational programs targeted to
minority populations, including Hispanic, Asian-American, Native Hawaiian, and
Pacific Islander populations, that are affected by acquired bone marrow failure
diseases.
(2)Programs under subsection (a) may carry out activities
that include—
(A)making information
about treatment options and clinical trials for acquired bone marrow failure
diseases publicly available; and
(B)providing referral
services for treatment options and clinical trials.
(b)In this section, the term acquired
bone marrow failure disease has the meaning given such term in section
317U(c).
.
4.Best practices
for diagnosis of and care for individuals with acquired bone marrow failure
diseasesPart B of title III
of the Public Health Service Act (42 U.S.C. 243 et seq.), as amended
by section 2, is further amended by inserting after section 317U the
following:
317V.Best practices
for diagnosis of and care for individuals with acquired bone marrow failure
diseases
(a)The Secretary, acting through the Director
of the Agency for Healthcare Research and Quality, may award grants to
researchers to study best practices with respect to diagnosing acquired bone
marrow failure diseases and providing care to individuals with such
diseases.
(b)In this section, the term acquired
bone marrow failure disease has the meaning given such term in section
317U(c).
.
Passed the House of Representatives September 30
(legislative day September 29), 2010.
Lorraine C. Miller,
Clerk